Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics Inc
WKN: A2AP32 / Symbol: PTGX / Name: Protagonist / Aktie / Micro Cap /
116,00 €
-0,86 %
Protagonist Therapeutics (PTGX) was upgraded by Wolfe Research to "strong-buy".
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics (PTGX) had its "buy" rating reaffirmed by TD Cowen.
Ratings data for PTGX provided by MarketBeat


Neueste Beiträge
PiotrSwierczewski in Discuss Net Insight Ab B